Drug Type Mesenchymal stem cell therapy |
Synonyms Adipose stem cell therapy KSTEMCELL, Autologous adipose stem cells KSTEMCELL, Astrostem |
Target- |
Mechanism Cartilage replacements, Cell replacements, Osteogenesis stimulants + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 3 | KR | 11 Jun 2019 | |
Osteoarthritis | Phase 2 | KR | 27 May 2019 | |
Alzheimer Disease | Phase 1 | US | 04 Mar 2017 | |
Spinal Cord Injuries | Phase 1 | KR | 27 Jan 2013 | |
Femur Head Necrosis | Phase 1 | KR | 12 May 2012 | |
Thromboangiitis Obliterans | Phase 1 | KR | 01 Dec 2007 | |
Cerebral Palsy | Phase 1 | KR | - | - |
Facial Hemiatrophy | Discovery | KR | - | |
Facial Hemiatrophy | Discovery | KR | - | |
Peripheral Vascular Diseases | Discovery | KR | - |
Phase 2 | 28 | (JointStem) | fhffobfawy(ynfomzqmgz) = ulxyykxrbn zuizohyemg (qlcrxdqymz, areztfgeju - qjiwghkzps) View more | - | 13 Jul 2021 | ||
(Synvisc-One) | (mfwjdokhkz) = damnexxnpt gjdxdzrvon (dlsbvwujvg, lrqtovwvfc - vuexmeyubc) View more | ||||||
Phase 1/2 | 21 | (AstroStem) | (lupinyxhxa) = uwseovqoqg tioztdxipc (fhoqgfbduc, iestdyzbjc - zismgeotne) View more | - | 09 Jul 2021 | ||
Placebo-Control (Placebo-Control) | (lupinyxhxa) = zsstwigpch tioztdxipc (fhoqgfbduc, wpxxcsgolr - wxyrystcbx) View more |